Dr.LeslieOBGYN said:Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.
Thank you for spelling out the reasoning rather than just the conclusion.
Clinical perspective, offered as context rather than as advice.
I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both. The key is finding a reliable 503B pharmacy with independent testing.
CarlaRPh_TPA said:Compounding pharmacy customer here with experience relevant to compounded supply.
Price comparison for compounded supply across sources I've used:
| Source | Monthly Cost | Type | Purity Verified |
|---|---|---|---|
| Brand (Ozempic) | $982 | FDA-approved | N/A (pharma) |
| 503B Compounding | $162 | cGMP compounded | Yes (in-house) |
| 503A Compounding | $92 | Patient-specific | Varies |
| Research peptide | $47 | Not for human use | Often Janoshik |
I use the 503B option — best balance of quality, cost, and legality. The brand price is insane but insurance can help if you qualify.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsDadBodDave said:The shortage clause is the answer to the second question and it is a subtraction rather than an addition.
Compounded has been just as effective for me. If compounded supply is the concern, the COA from my 503B pharmacy shows 99.1% purity. Verified by Janoshik.